Clinical Trials for Summit Therapeutics

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer

Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma

Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

Ivonescimab for the Treatment of Thymic Cancer

Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

Phase III Study of AK112 for NSCLC Patients

A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer